They voted in unison for the prominent purveyor of vaccine misinformation even as it became even clearer that they were ...
The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...
Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know ...
Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...
A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...
Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the ...
22h
The Times (Shreveport) on MSNWhat did Louisiana Senator Bill Cassidy say about the future of vaccine access in America?Republican Louisiana Senator Bill Cassidy cast the swing vote on advancing President Trump's nomination of RFK Jr. to lead ...
Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.
Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...
Robert F. Kennedy Jr’s message of eliminating toxins and investigating public health agencies has resonated among a key group ...
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results